https://www.fiercepharma.com/pharma/jpm25-after-taking-wheel-acadia-new-ceo-catherine-owen-adams-looks-steer-toward-1b-2025
After reading this article, I bet Acadia and others would die for 2591's safety and tolerability profile. However, Acadia can't afford Neuren with the stated $700 million it has for themselves in 'potential development deals'
https://www.fiercepharma.com/pharma/jpm25-after-taking-wheel-acad...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.29 |
Change
0.660(3.97%) |
Mkt cap ! $2.177B | |||
| Open | High | Low | Value | Volume |
| $16.80 | $17.34 | $16.63 | $9.078M | 529.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1334 | $17.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.30 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |